Mar 13
|
MSD to push for approval of HIV combo after Phase III success
|
Mar 13
|
Merck & Co., Inc. (NYSE:MRK) Looks Interesting, And It's About To Pay A Dividend
|
Mar 12
|
Why Merck & Co., Inc. (MRK) is the Best Pharma Stock to Buy According to Hedge Funds
|
Mar 12
|
Merck Plans Regulatory Submission For Two-Drug Regime For HIV Infection By Mid-2025
|
Mar 12
|
Merck Announces Positive Data from Phase 3 Trials that Show the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) Maintained HIV-1 Viral Suppression at Week 48
|
Mar 12
|
Merck & Co., Inc. (MRK): Among Dobermans of the Dow to Buy
|
Mar 11
|
Merck (NYSE:MRK) Unveils US$1 Billion Durham Facility For Advanced Vaccine Manufacturing Expansion
|
Mar 11
|
Zacks Investment Ideas feature highlights: Molson Coors, Merck & Co. and Deutsche Telekom
|
Mar 11
|
Merck Unveils New Facility to Increase Vaccine Production Capacity
|
Mar 11
|
Merck & Co. (MRK): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now
|
Mar 11
|
Wall Street Analysts Think This Medical Dividend Stock Could Have Massive 82% Upside
|
Mar 10
|
Merck & Co. (MRK): One of the Most Undervalued US Stocks to Buy According to Hedge Funds
|
Mar 10
|
Safe Haven Stocks: 3 Top Picks for Navigating Volatility
|
Mar 10
|
Stock market sell-off: Why these stocks are in the green amid the pain
|
Feb 24
|
Merck to Participate in the TD Cowen 45th Annual Health Care Conference
|
Feb 23
|
Merck & Co., Inc. (MRK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
|
Feb 22
|
Merck & Co., Inc. (MRK): Among the Most Expensive Stocks Insiders Are Buying Recently
|
Feb 21
|
2 Healthcare Stocks with Big Upside and 1 to Skip
|
Feb 18
|
Merck & Co., Inc. (MRK): Among the Cheap High Dividend Stocks to Invest In Now
|
Feb 18
|
Is Merck & Co., Inc. (MRK) the Best Very Cheap Stock To Buy Right Now?
|